None listed
Conditions
Brief summary
Early detection of cancer and advances in cancer treatment has allowed most people with cancer to survive at least 5 years from diagnosis. The wide range of needs associated with cancer survivorship is often overlooked. Follow-up care has been adopted to aid the detection of recurrence, promote behavioural changes and facilitate psychosocial adjustments. Follow-up care when performed by cancer specialists is not cost-effective and puts undue load on the cancer clinics. Most recurrences occur between appointments with a specialist and are detected by general practitioners (GPs). Currently, services offered by allied health professionals (AHP) are uncoordinated; patients thus face the likelihood of duplication of treatments, increased financial burden or incomplete care. We propose a feasibility study for cancer follow-up within a primary care setting based on the multi-disciplinary team (MDT) model.
Interventions
No defined treatment. The needs of 30 breast cancer follow-up patients will be assessed at the beginning of the study by a team of medical and allied health professionals (MDT, multidisciplinary team). The cancer care coordinator will forward the patient-management recommendations of the team to the patients' general practitioner (GP). The GP will subsequently consult the patient and decide whether to adopt the recommendations received: referring the patient to the nominated allied health profes
No defined treatment. The needs of 30 breast cancer follow-up patients will be assessed at the beginning of the study by a team of medical and allied health professionals (MDT, multidisciplinary team). The cancer care coordinator will forward the patient-management recommendations of the team to the patients' general practitioner (GP). The GP will subsequently consult the patient and decide whether to adopt the recommendations received: referring the patient to the nominated allied health professionals within the community. To facilitate communication amongst health professionals, the patient's GP and the nominated allied health professionals will have free access to a web-based information sharing platform. The treatments provided will depend on the needs of the patients as assessed at the beginning of the study.
Sponsors
Prof Moyez Jiwa
Study design
Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
45 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
The inclusion criteria are as follow: Have been diagnosed with breast cancer, age between 45 - 65 years old, have completed adjuvant treatment, are disease free, and are between 12 - 24 months post-diagnosis.
Exclusion criteria
The exclusion criteria are: Less than 45 or over 65 years old of age, undergoing active treatment, and are not disease free
Outcome results
None listed